This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C Bottomley , I Nazareth , F Torres-Gonzalez , I Svab , HI Maaroos , MI Geerlings , M Xavier , S Saldivia , M King (2010). Comparison of risk factors for the onset and maintenance of depression. Bristish Journal of Psychiatry
P Cassano , M Fava (2002). Depression and public health: an overview. Journal of Psychosomatic Research
P Cuijpers , A van Straten , F Smit , C Mihalopoulos , A Beekman (2008). Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. American Journal of Psychiatry
RL Dunn , JM Donoghue , RJ Ozminkowski , D Stephenson , TR Hylan (1999). Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. Journal of Psychopharmacology
TL Feenstra , PM van Baal , MO Jacobs-van der Bruggen , RT Hoogenveen , GJ Kommer , CA Baan (2011). Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention. Cost Effectiveness and Resource Allocation 9, 14.
S Hollinghurst , TJ Peters , S Kaur , N Wiles , G Lewis , D Kessler (2010). Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. British Journal of Psychiatry
C Jenkinson , R Layte , D Jenkinson , K Lawrence , S Petersen , C Paice , J Stradling (1997). A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? Journal of Public Health Medicine 19, 179–186.
E Kaltenthaler , P Shackley , K Stevens , C Beverley , G Parry , J Chilcott (2002). A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technology Assessment
T Kendrick , R Peveler , L Longworth , D Baldwin , M Moore , J Chatwin , A Thornett , J Goddard , M Campbell , H Smith , M Buxton , C Thompson (2006). Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial. British Journal of Psychiatry 188, 337–345.
M King , C Walker , G Levy , C Bottomley , P Royston , S Weich , JA Bellon-Saameno , B Moreno , I Svab , D Rotar , J Rifel , HI Maaroos , A Aluoja , R Kalda , J Neeleman , MI Geerlings , M Xavier , I Carraca , M Goncalves-Pereira , B Vicente , S Saldivia , R Melipillan , F Torres-Gonzalez , I Nazareth (2008). Development and validation of an international risk prediction algorithm for episodes of major depression in general practice attendees: the PredictD study. Archives of General Psychiatry
R Mann , S Gilbody , D Richards (2009). Putting the ‘Q’ in depression QALYs: a comparison of utility using EQ-5D and SF-6D health related quality of life measures. Social Psychiatry and Psychiatric Epidemiology 44, 134–136.
C Mihalopoulos , T Vos , J Pirkis , F Smit , R Carter (2011). Do indicated preventive interventions for depression represent good value for money?
Australian and New Zealand Journal of Psychiatry
R Peveler , T Kendrick , M Buxton , L Longworth , D Baldwin , M Moore , J Chatwin , J Goddard , A Thornett , H Smith , M Campbell , C Thompson (2005). A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technology Assessment
9, 1–134, iii.
F Smit , G Willemse , M Koopmanschap , S Onrust , P Cuijpers , A Beekman (2006). Cost-effectiveness of preventing depression in primary care patients: randomised trial. British Journal of Psychiatry 188, 330–336.
V Spek , P Cuijpers , I Nyklicek , N Smits , H Riper , J Keyzer , V Pop (2008). One-year follow-up results of a randomized controlled clinical trial on internet-based cognitive behavioural therapy for subthreshold depression in people over 50 years. Psychological Medicine 38, 635–639.
CM Thomas , S Morris (2003). Cost of depression among adults in England in 2000. British Journal of Psychiatry
M Valenstein , S Vijan , JE Zeber , K Boehm , A Buttar (2001). The cost-utility of screening for depression in primary care. Annals of Internal Medicine 134, 345–360.
M van den Berg , F Smit , T Vos , PH van Baal (2011). Cost-effectiveness of opportunistic screening and minimal contact psychotherapy to prevent depression in primary care patients. PLoS One
S Weich , I Nazareth , L Morgan , M King (2007). Treatment of depression in primary care. Socio-economic status, clinical need and receipt of treatment. British Journal of Psychiatry